OPN4 and chronic inflammatory demyelinating polyradiculoneuropathy: Notably, the decline in melanopsin-mediated PIPRred–blue correlated with the severity of CIDP symptoms, i.e. the reported disability grew together with the lowering of mRCG responsivity.